SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CABRINI, Giulio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 895
EU - Europa 278
AS - Asia 202
OC - Oceania 1
Totale 1.376
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 895
IT - Italia 121
CN - Cina 84
HK - Hong Kong 42
PL - Polonia 42
SE - Svezia 32
TR - Turchia 27
DE - Germania 25
GB - Regno Unito 22
SG - Singapore 21
UA - Ucraina 21
ID - Indonesia 17
VN - Vietnam 7
FI - Finlandia 6
FR - Francia 3
BE - Belgio 2
IR - Iran 2
MK - Macedonia 2
AU - Australia 1
IL - Israele 1
NO - Norvegia 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 1.376
Salva come PNG Salva come JPEG
Città #
Fairfield 126
Woodbridge 110
Ashburn 101
Chandler 73
Ferrara 67
Houston 62
Wilmington 48
Cambridge 46
Seattle 43
Hong Kong 42
Warsaw 41
Ann Arbor 32
Jacksonville 30
Beijing 25
Shanghai 21
Izmir 19
Addison 18
Jakarta 17
Princeton 17
Singapore 11
Washington 11
Milan 10
Nanjing 10
Boardman 9
Bremen 8
Dong Ket 7
San Diego 6
Hebei 5
Mountain View 5
Dearborn 4
Ferrara di Monte Baldo 4
Jiaxing 4
Los Angeles 4
Nanchang 4
Bologna 3
Changsha 3
Chicago 3
Harvard 3
Jinan 3
London 3
Norwalk 3
Redwood City 3
Trieste 3
Venice 3
Auburn Hills 2
Augusta 2
Bacoli 2
Brindisi 2
Cesena 2
Chongqing 2
Des Moines 2
Groton 2
Guarda Veneta 2
Munich 2
Naples 2
Paris 2
Pescara 2
Tappahannock 2
Albuquerque 1
Ardabil 1
Bevagna 1
Broomfield 1
Brussels 1
Falls Church 1
Frankfurt am Main 1
Fremont 1
Guangzhou 1
Haikou 1
Helsinki 1
Hounslow 1
Jinhua 1
Kilburn 1
Leawood 1
Leuven 1
Lisbon 1
Monmouth Junction 1
North Chelmsford 1
Parma 1
Perth 1
Redmond 1
Riyadh 1
Saint Louis 1
San Donà di Piave 1
Shenyang 1
Sindelfingen 1
Tianjin 1
Wuhan 1
Totale 1.127
Salva come PNG Salva come JPEG
Nome #
Differential Effects of Angelicin Analogues on NF-kB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 164
Exploring the effect of chirality on the therapeutic potential of N-alkyl-deoxyiminosugars: anti-inflammatory response to Pseudomonas aeruginosa infections for application in CF lung disease 142
MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells 132
Mitochondrial Ca2+-dependent NLRP3 activation exacerbates the Pseudomonas aeruginosa-driven inflammatory response in cystic fibrosis 131
An antisense peptide nucleic acid against Pseudomonas aeruginosa inhibiting bacterial-induced inflammatory responses in the cystic fibrosis IB3-1 cellular model system 120
Anti-inflammatory activity of novel 4,6,4’-trimethylangelicin’s analogues: effects on the NF-kB activity and IL-8 expression in Cystic Fibrosis IB3-1 cells 101
Molecular mechanism of action of trimethylangelicin derivatives as CFTR modulators 95
A new method for measuring local ATP release at the extracellular surface of live intact cells 78
A PNA-based masking strategy for CFTR upregulation by targeting miR-145-5p binding sites of CFTR mRNA 51
Pharmacological modulation of mitochondrial calcium uniporter controls lung inflammation in cystic fibrosis 48
Mitochondrial Ca2+-dependent inflammasome activation exacerbates the P. aeruginosa-driven inflammatory response 47
A Molecular Signature associated with prolonged survival in Glioblastoma patients treated with Regorafenib 46
Role of Cystic Fibrosis Bronchial Epithelium in Neutrophil Chemotaxis 35
A Peptide-Nucleic Acid Targeting miR-335-5p Enhances Expression of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene with the Possible Involvement of the CFTR Scaffolding Protein NHERF1 34
A peptide nucleic acid (PNA) masking the miR-145-5p binding site of the 3’UTR of the cystic fibrosis transmembrane conductance regulator (CFTR) mRNA enhances CFTR expression in Calu-3 cells 33
Treatment of human airway epithelial Calu-3 cells with a peptide-nucleic acid (PNA) targeting the microRNA miR-101-3p is associated with increased expression of the cystic fibrosis Transmembrane Conductance Regulator () gene 29
509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis 27
SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation 25
miRNAs in Serum Exosomes for Differential Diagnosis of Brain Metastases 25
Combined Treatment of Bronchial Epithelial Calu-3 Cells with Peptide Nucleic Acids Targeting miR-145-5p and miR-101-3p: Synergistic Enhancement of the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene 21
New TMA (4,6,4'-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease 20
Overview of CF lung pathophysiology 16
Revealing the microRNA-transcription factors network in cystic fibrosis:from microRNA therapeutics to precision medicine (CF-miRNA-THER) FFC 7/2018 15
CFTR Modulators and Reduction of Airway Inflammation in Cystic Fibrosis: How Much is Enough? 12
Revisiting Host-Pathogen Interactions in Cystic Fibrosis Lungs in the Era of CFTR Modulators 3
Totale 1.450
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.382
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.382
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020302 29 8 13 32 62 39 21 21 29 24 18 6
2020/2021272 13 5 9 16 12 22 40 29 20 40 34 32
2021/2022191 9 8 18 6 9 8 21 13 13 12 25 49
2022/2023194 21 34 4 19 22 14 25 10 19 1 14 11
2023/2024260 13 20 16 3 64 45 9 21 4 3 6 56
Totale 1.450